🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open-label , multicenter randomized controlled trial...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-15
Trial ID
NCT04131231
Treatments Being Tested
Multidrug-resistant tuberculosis (MDR-TB) has emerged as a challenge worldw...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2009-06-01
Trial ID
NCT03069534
Treatments Being Tested
This study will find the highest acceptable treatment dose of cord blood, c...
Status
Terminated
Location
Beth Israel Deaconess Medical Center
Start Date
2016-07-11
Trial ID
NCT02781467
Treatments Being Tested
For several years there has been interest in why some people with HIV-1 pro...
Status
Terminated
Location
St. Stephen's AIDS Trust
Start Date
2009-09
Trial ID
NCT01130376
Treatments Being Tested
The purposes of this study are fourfold. It will 1) determine what dose of ...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2000-04-28
Trial ID
NCT00005655
A Phase 1/2a Open Label Multicenter, Non-Randomized, Trial to Assess the Sa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-09
Trial ID
NCT05218408
Treatments Being Tested
This study is a randomized, controlled, single-center clinical study to eva...
Status
Unknown
Location
The Second Xiangya Hospital of Central South University
Start Date
2021-06-16
Trial ID
NCT04893980
Treatments Being Tested
TRANSREG will assess the safety and biological efficacy of low-dose IL2 as ...
Status
Completed
Location
Henri Mondor - Médecine Interne
Start Date
2014-01-06
Trial ID
NCT01988506
Treatments Being Tested
After complete remission, elderly AML patients cannot tolerate hematopoieti...
Status
Unknown
Location
The first affiliated hospital of Xi'an jiaotong university
Start Date
2021-02-01
Trial ID
NCT04687657
Treatments Being Tested
This study will find the maximum tolerated dose (MTD) of CYNK-101 which con...
Status
Terminated
Location
Scripps Health
Start Date
2022-04-14
Trial ID
NCT05207722